An examination of the operational feasibility and effectiveness of remote monitoring of salivary glycated albumin using a smartphone app for glycemic management in a social implementation project.

未提供0 个研究点目标入组 150 人开始时间: 待定

适应症

试验速览

暂无简介。

•Participants who meet all of the following criteria will be eligible for this study:
•The most recent HbA1c test result from a health checkup or outpatient test is 5.6% or higher.
•Aged 20 years or older at the time of informed consent.
•Owns a smartphone capable of running the required application.
•Has the intention to improve their lifestyle habits.
•Able to self-collect saliva samples at home on designated days during the weekly measurement period, and promptly drop them off in a refrigerated post box located at a post office.
•Able to collect and submit saliva samples and complete questionnaires at baseline (start), at the end of the weekly measurement period, and at the end of the follow-up period.
•Understands the contents of the informed consent document explaining the study's purpose and methodology, and has provided written consent to participate.
•If currently receiving outpatient treatment for diabetes, has obtained written approval from their primary care physician to participate in this study.

•Individuals who meet any of the following criteria will be excluded from the study:
•Currently hospitalized for medical treatment.
•Having comorbid conditions or symptoms known to cause a discrepancy between GA (glycated albumin) levels and blood glucose levels (hyperthyroidism, nephrotic syndrome, ascites [peritoneal dialysis], steroid-induced diabetes, high BMI, hypothyroidism, liver cirrhosis, or malnutrition).
•Having special dietary or exercise restrictions prescribed by a physician due to other symptoms or conditions, and whose participation is deemed difficult by the Principal Investigator.
•Otherwise judged inappropriate for participation by the Principal Investigator.

发起方

未提供